Keytruda 50 MG Injection
- RxCUI
- 1657749
- RxNorm name
- Keytruda 50 MG Injection
- Display name
- Keytruda 50 MG Injection
- Full name
- Keytruda 50 MG Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:08
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125514 | Keytruda | pembrolizumab | 351(a) | Disc | 2026-08-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| KEYTRUDA | PEMBROLIZUMAB | Merck Sharp & Dohme LLC | 9333c79b-d487-4538-a9f0-71b91a02b287 | 2026-07-10 | Warnings, Adverse reactions | 1657749 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 9333c79b-d487-4538-a9f0-71b91a02b287 | Keytruda 50 MG Injection [PSN] · pembrolizumab 50 MG Injection [Keytruda] [SBD] · Keytruda 50 MG Injection [SY] | 3 | 225 | These highlights do not include all the information needed to use KEYTRUDA safely and effectively. See full prescribing information for KEYTRUDA. KEYTRUDA ® (pembrolizumab) injection, for intravenous use Initial U.S. Approval: 2014 | 20260512 |